Underlying diseases of the study population (n = 127)
| N (%) | |
|---|---|
| BM, bone marrow; PBSC, peripheral blood stem cell. | |
| *Treated with chemotherapy. | |
| †Others: myelodysplastic syndrome (2), non-Hodgkin’s disease (2), multiple myeloma (1). | |
| Haematopoietic stem cell transplantation (HSCT) | 40 |
| Allogenic BM | 6 (15) |
| Autologous PBSC | 4 (10) |
| Allogenic PBSC | 30 (75) |
| Haematological malignancies (HM)* | 53 |
| Acute myeloid leukaemia | 20 (23) |
| Hodgkin’s lymphoma | 12 (13) |
| Acute lymphoid leukaemia | 7 (9) |
| Chronic lymphoid leukaemia | 5 (9) |
| Chronic myeloid leukaemia | 4 (7) |
| Others† | 5 (9) |
| Solid organ transplantation (SOT) | 34 |
| Renal | 14 (41) |
| Liver | 9 (26) |
| Cardiac | 7 (21) |
| Renopancreatic | 4 (12) |